88 related articles for article (PubMed ID: 32999190)
1. USP16 Regulates the Stability and Function of LDL receptor by Deubiquitination.
Li Y; Rao Y; Zhu H; Jiang B; Zhu M
Int Heart J; 2020; 61(5):1034-1040. PubMed ID: 32999190
[TBL] [Abstract][Full Text] [Related]
2. The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL.
Nelson JK; Sorrentino V; Avagliano Trezza R; Heride C; Urbe S; Distel B; Zelcer N
Circ Res; 2016 Feb; 118(3):410-9. PubMed ID: 26666640
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake.
Nelson JK; Cook EC; Loregger A; Hoeksema MA; Scheij S; Kovacevic I; Hordijk PL; Ovaa H; Zelcer N
J Biol Chem; 2016 Feb; 291(9):4813-25. PubMed ID: 26719329
[TBL] [Abstract][Full Text] [Related]
4. NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation.
Pietiäinen V; Vassilev B; Blom T; Wang W; Nelson J; Bittman R; Bäck N; Zelcer N; Ikonen E
J Cell Sci; 2013 Sep; 126(Pt 17):3961-71. PubMed ID: 23813961
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor (NGF) and pro-NGF increase low-density lipoprotein (LDL) receptors in neuronal cells partly by different mechanisms: role of LDL in neurite outgrowth.
Do HT; Bruelle C; Pham DD; Jauhiainen M; Eriksson O; Korhonen LT; Lindholm D
J Neurochem; 2016 Jan; 136(2):306-15. PubMed ID: 26484803
[TBL] [Abstract][Full Text] [Related]
6. Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.
Sorrentino V; Zelcer N
Curr Opin Lipidol; 2012 Jun; 23(3):213-219. PubMed ID: 22510808
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1.
Wang JQ; Lin ZC; Li LL; Zhang SF; Li WH; Liu W; Song BL; Luo J
J Biol Chem; 2021; 296():100032. PubMed ID: 33154164
[TBL] [Abstract][Full Text] [Related]
8. Circulating low density lipoprotein (LDL).
Khosravi M; Hosseini-Fard R; Najafi M
Horm Mol Biol Clin Investig; 2018 Jul; 35(2):. PubMed ID: 30059347
[TBL] [Abstract][Full Text] [Related]
9. RNF130 Regulates LDLR Availability and Plasma LDL Cholesterol Levels.
Clifford BL; Jarrett KE; Cheng J; Cheng A; Seldin M; Morand P; Lee R; Chen M; Baldan A; de Aguiar Vallim TQ; Tarling EJ
Circ Res; 2023 Mar; 132(7):849-863. PubMed ID: 36876496
[TBL] [Abstract][Full Text] [Related]
10. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
11. Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.
Yang JH; Bang MA; Jang CH; Jo GH; Jung SK; Ki SH
J Nutr Biochem; 2015 Nov; 26(11):1393-400. PubMed ID: 26320675
[TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein (LDL)-dependent uptake of Gram-positive lipoteichoic acid and Gram-negative lipopolysaccharide occurs through LDL receptor.
Grin PM; Dwivedi DJ; Chathely KM; Trigatti BL; Prat A; Seidah NG; Liaw PC; Fox-Robichaud AE
Sci Rep; 2018 Jul; 8(1):10496. PubMed ID: 30002483
[TBL] [Abstract][Full Text] [Related]
13. Effect of reduced low-density lipoprotein receptor level on HepG2 cell cholesterol metabolism.
Izem L; Rassart E; Kamate L; Falstrault L; Rhainds D; Brissette L
Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):81-9. PubMed ID: 9405278
[TBL] [Abstract][Full Text] [Related]
14. Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly.
Holla ØL; Cameron J; Berge KE; Ranheim T; Leren TP
BMC Cell Biol; 2007 Mar; 8():9. PubMed ID: 17328821
[TBL] [Abstract][Full Text] [Related]
15. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-148a regulates low-density lipoprotein metabolism by repressing the (pro)renin receptor.
Wang N; He L; Lin H; Tan L; Sun Y; Zhang X; Danser AHJ; Lu HS; He Y; Lu X
PLoS One; 2020; 15(5):e0225356. PubMed ID: 32437440
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAcylation stimulates the deubiquitination activity of USP16 and regulates cell cycle progression.
Zhao J; Hua J; Zhan Y; Chen C; Liu Y; Yang L; Wang H; Wang H; Li J
J Biol Chem; 2024 Apr; 300(4):107150. PubMed ID: 38462164
[TBL] [Abstract][Full Text] [Related]
18. Deferoxamine stimulates LDLR expression and LDL uptake in HepG2 cells.
Guillemot J; Asselin MC; Susan-Resiga D; Essalmani R; Seidah NG
Mol Nutr Food Res; 2016 Mar; 60(3):600-8. PubMed ID: 26577249
[TBL] [Abstract][Full Text] [Related]
19. Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein.
Sorrentino V; Fouchier SW; Motazacker MM; Nelson JK; Defesche JC; Dallinga-Thie GM; Kastelein JJ; Kees Hovingh G; Zelcer N
Eur Heart J; 2013 May; 34(17):1292-7. PubMed ID: 23324548
[TBL] [Abstract][Full Text] [Related]
20. Analysis of low-density lipoprotein catabolism by primary cultures of hepatic cells from normal and low-density lipoprotein receptor knockout mice.
Truong TQ; Auger A; Denizeau F; Brissette L
Biochim Biophys Acta; 2000 Apr; 1484(2-3):307-15. PubMed ID: 10760479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
